NHS criticised over HIV drug wait

National Health Service (NHS) England has been criticised after announcing its decision that it will not be providing the HIV treatment Truvada, which enables pre-exposure prophylaxis (PrEP).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

UK Supreme Court shoots down NHS £220m drug patent suit

2 July 2021 The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.

Big Pharma

NHS should finance HIV treatment PrEP, English High Court rules

2 August 2016 The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.

More features

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

NHS criticised over HIV drug wait

More on this story

Editor's picks

Editor's picks

More features